HIF1A and breast carcinoma: HIF‐1α expression is frequently increased in solid cancers, including nonsmall cell lung carcinoma (NSCLC), breast carcinoma, and colorectal carcinoma, and the prognosis of patients with HIF‐1α overexpression is very poor.2, 8, 9